首站-论文投稿智能助手
典型文献
运用筛选工具评价老年共病患者药物相关问题的临床研究
文献摘要:
目的:通过运用筛选工具,识别和减少老年共病患者药物相关问题(DRPs),优化药物治疗方案,改善多重用药,保障药物治疗安全、有效、经济.方法:随机抽取某医院老年病科2020年1月1日至2021年12月31日诊断为2型糖尿病、高血压病、冠心病的患者35例,运用Beers标准、STOPP标准和中国标准进行评价分析,总结检出的DRPs情况.结果:研究对象年龄(74.8±6.1)岁,服药数量(8.2±2.0)种,32人检出DRPs 62项.其中,与药物有关的DRPs 43项,与疾病状态有关的DRPs 12项,与药物相互作用有关的DRPs 7项.结论:老年共病患者药物相关问题较为突出,临床药师介入药物治疗实施药学监护,能及时发现和消除DRPs,优化药物治疗方案,显著改善患者多重用药,保障患者用药安全.
文献关键词:
药物疗法管理;药物疗法;联合;药学服务;慢性病共病;老年人;多重用药;药物相关问题
作者姓名:
邓利娟;颜志婷
作者机构:
萍乡市人民医院,江西 萍乡 337000
文献出处:
引用格式:
[1]邓利娟;颜志婷-.运用筛选工具评价老年共病患者药物相关问题的临床研究)[J].药品评价,2022(20):1256-1259
A类:
B类:
老年共病,药物相关问题,DRPs,优化药物治疗,多重用药,治疗安全,随机抽取,老年病科,高血压病,冠心病,Beers,STOPP,中国标准,评价分析,服药,疾病状态,药物相互作用,临床药师,入药,施药,药学监护,患者用药安全,药物疗法管理,药学服务,慢性病共病
AB值:
0.287388
相似文献
神经精神药理学治疗药物监测共识指南:2017版
C.Hiemke;N.Bergemann;H.W.Clement;A.Conca;J.Deckert;K.Domschke;G.Eckermann;K.Egberts;M.Gerlach;C.Greiner;G.Gründer;E.Haen;U.Havemann-Reinecke;G.Hefner;R.Helmer;G.Janssen;E-.Jaquenoud;G.Laux;T.Messer;R.M?ssner;M.J.Müller;M.Paulzen;B.Pfuhlmann;P.Riederer;A.Saria;B.Schoppek;G.Schoretsanitis;M.Schwarz;M.Silva Gracia;B.Stegmann;W.Steimer;J.C.Stingl;M.Uhr;S.Ulrich;S.Unterecker;R.Waschgler;G.Zernig;G.Zurek;P.Baumann;李文标;果伟;贺静;鲍爽;路钊;牛梦溪;阮灿军;臧彦楠;王勇;张玲;刘辰庚;李洁-Department of Psychiatry and Psychotherapy,University Medical Center of Mainz,Mainz,Germany;Institute of Clinical Chemistry and Laboratory Medicine,University Medical Center of Mainz,Mainz,Germany;Kitzberg Hospitals,Center for Psychosomatic Medicine and Psychotherapy,Bad Mergentheim,Germany;Department of Child and Adolescent Psychiatry,University of Freiburg,Freiburg,Germany;Servizio Psichiatrico del Comprensorio Sanitario di Bolzano,Bolzano,Italy;Department of Psychiatry,Psychotherapy and Psychosomatics,University Hospital of Würzburg,Germany;Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg,Freiburg,Germany;Psychiatric Hospital,Kaufbeuren,Germany;Department of Child and Adolescent Psychiatry,Psychosomatics and Psychotherapy,Center of Mental Health,University Hospi-tal of Würzburg,Germany;Federal Institute for Drugs and Medical Devices (BfArM),Bonn,Germany;Department of Psychiatry,Psychotherapy and Psychosomatics,RWTH Aachen University,Aachen,and JARA–Translational Brain Medicine,Aachen,Germany;Clinical Pharmacology,Department of Psychiatry and Psychotherapy and Department of Pharmacology and Toxicology,Uni-versity of Regensburg,Regensburg,Germany;Department of Psychiatry and Psychosomatics,University of G?ttingen,G?ttingen,Germany;Psychiatric Hospital,Vitos Klinik,Eichberg,Eltville,Germany;Center of Epilepsy,Bielefeld,Germany;Medical Laboratory Stein,Limbach Group,M?nchengladbach,Germany;Psychiatric Hospital,K?nigsfelden,Brugg,Aargau,Switzerland;Institute of Psychological Medicine,Haag in Oberbayern,Germany;Danuviuskliniken,Psychiatric Hospital,Pfaffenhofen,Germany;Department of Psychiatry and Psychotherapy,University of Tübingen,Tübingen,Germany;Psychiatric Hospitals Oberberggruppe,Berlin,Germany;Psychiatric Hospital Weisser Hirsch,Dresden,Germany;Experimental Psychiatry Unit,Department of Psychiatry1,Medical University of Innsbruck,Innsbruck,Austria;kbo-Isar-Amper Klinikum München-Ost,Psychiatric Hospital,Munich-Haar,Germany;Department of Psychiatry,University of Bern,Bern,Switzerland;Department of Laboratory Medicine,Ludwig Maximilian University,Munich,Germany;Institute of Clinical Chemistry and Pathobiochemistry,Technical University Munich,Munich,Germany;Max Planck Institute of Psychiatry,Munich,Germany;Aristo Pharma GmbH,Berlin,Germany;Psychiatric Hospital,Feldkirch,Austria;Private Practice for Psychotherapy and Court-Certified Witness,Hall in Tirol,Austria;Medical Laboratory Bremen,Bremen,Germany;Department of Psychiatry,University of Lausanne,Prilly-Lausanne,Switzerland;中国 北京 首都医科大学附属北京安定医院,国家精神心理疾病临床医学研究中心,精神疾病诊断与治疗北京重点实验室;中国 天津 天津市安定医院
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。